Erratum to: In vitro and in vivo activity of miR-92a–Locked Nucleic Acid (LNA)–Inhibitor against endometrial cancer

Abstract

Cell proliferation assay Proliferation was measured using Delfia cell proliferation kit (Perkin-Elmer, Waltham, MA, USA) according to manufacturer protocol. BrdU incorporation was measured by time–resolved fluorescence 48 h after transfection using VictorX4 multimode plate reader (Perkin-Elmer, Waltham, MA, USA). All experiments were performed in… (More)
DOI: 10.1186/s12885-016-2971-0

Topics

Cite this paper

@inproceedings{Torres2016ErratumTI, title={Erratum to: In vitro and in vivo activity of miR-92a–Locked Nucleic Acid (LNA)–Inhibitor against endometrial cancer}, author={Anna Torres and Joanna Kozak and Agnieszka Korolczuk and Paulina Wdowiak and Ewa Domańska-Glonek and Ryszard Maciejewski and Kamil Torres}, booktitle={BMC Cancer}, year={2016} }